Mattel Gains Over 2% – What’s Going On?

Mattel shares surge as the company announces plans for a feature-length film based on "Bob the Builder," featuring Anthony Ramos and celebrating Caribbean Latin nations' vibrant textures.

Mattel, Inc. (NASDAQ:MAT) shares are trading higher on Friday.

Yesterday, the company announced plans to develop a feature-length film based on Bob the Builder, the beloved animated children’s series.

The movie will be developed together with ShadowMachine, Nuyorican Productions, and Anthony Ramos, the company said in a press release.

The film will star Grammy-winning and Golden Globe and Emmy-nominated actor and recording artist Anthony Ramos, for the voice of Roberto, “Bob,” travels to the enchanting Island of Puerto Rico for a significant construction job. 

Bob’s journey will celebrate the vibrant and colorful textures of the Caribbean Latin nations and their people, the company said.

Robbie Brenner, President of Mattel Films, said: “We are thrilled to collaborate with our brilliant partners Anthony Ramos, Jennifer Lopez, Elaine Goldsmith-Thomas, Benny Medina, Alex Bulkley, Corey Campodonico, and Felipe Vargas on Bob the Builder, our first animated theatrical film.”

Following the success of Warner Bros’ “Barbie” movie, which grossed over $1.4 billion at the box office, Mattel has unveiled “Bob the Builder” as the latest addition to its slate of film and television projects, Reuters said in a report.

In 2011, Mattel acquired Hit, the owner of rights to “Bob the Builder,” “Thomas & Friends,” and other preschool properties, for $680 million.

Price Action: MAT shares are trading higher by 2.32% to $18.52 on the last check Friday. 

Photo via Company

Total
0
Shares
Related Posts
Read More

HIVE Blockchain Provides November Production 2022 Update; Produced 264 Bitcoin; Received 262 Units Of Its New HIVE BuzzMiner, Powered By The Intel Blockscale ASIC. An Additional 420 Units Are Expected To Be Received In The Next Week

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated September 2, 2022 to its amended and restated short form base shelf prospectus dated

HIVE